X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (529) 529
Publication (49) 49
Conference Proceeding (14) 14
Patent (10) 10
Book Chapter (9) 9
Book / eBook (4) 4
Dissertation (4) 4
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (197) 197
index medicus (161) 161
female (153) 153
male (147) 147
oncology (136) 136
middle aged (130) 130
adult (119) 119
aged (112) 112
cancer (63) 63
aged, 80 and over (59) 59
neoplasms - drug therapy (54) 54
treatment outcome (49) 49
research (48) 48
care and treatment (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
pharmacology & pharmacy (40) 40
analysis (39) 39
tumors (39) 39
chemotherapy (38) 38
medicine & public health (37) 37
pancreatic cancer (37) 37
pharmacokinetics (34) 34
dose-response relationship, drug (31) 31
animals (30) 30
clinical trials (30) 30
antineoplastic agents - administration & dosage (29) 29
colorectal neoplasms - drug therapy (29) 29
antineoplastic agents - pharmacokinetics (28) 28
health aspects (26) 26
studies (26) 26
surgery (26) 26
antineoplastic agents - adverse effects (25) 25
antineoplastic agents - therapeutic use (25) 25
maximum tolerated dose (25) 25
patients (25) 25
colorectal neoplasms - pathology (24) 24
gemcitabine (24) 24
article (23) 23
camptothecin - analogs & derivatives (23) 23
india (23) 23
irinotecan (23) 23
pharmacology/toxicology (23) 23
deoxycytidine - analogs & derivatives (22) 22
drug administration schedule (22) 22
prognosis (21) 21
solid tumors (21) 21
disease-free survival (20) 20
neoplasm staging (20) 20
neoplasms - pathology (19) 19
risk factors (19) 19
trial (19) 19
area under curve (18) 18
deoxycytidine - administration & dosage (18) 18
drug therapy (18) 18
expression (18) 18
metastasis (18) 18
neoplasms - metabolism (18) 18
pharmacology (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
camptothecin - administration & dosage (17) 17
carcinoma (17) 17
dosage and administration (17) 17
adenocarcinoma - drug therapy (16) 16
meteorology & atmospheric sciences (16) 16
oxaliplatin (16) 16
rats (16) 16
survival (16) 16
therapy (16) 16
abridged index medicus (15) 15
chemistry (15) 15
pancreatic neoplasms - drug therapy (15) 15
research article (15) 15
survival analysis (15) 15
young adult (15) 15
adenocarcinoma (14) 14
adolescent (14) 14
cancer therapies (14) 14
disease progression (14) 14
mice (14) 14
pancreatic neoplasms - pathology (14) 14
usage (14) 14
cancer research (13) 13
colorectal cancer (13) 13
combination (13) 13
earth sciences (13) 13
environmental sciences (13) 13
follow-up studies (13) 13
hiv (13) 13
medical research (13) 13
medicine (13) 13
medicine, general & internal (13) 13
microbiology (13) 13
organoplatinum compounds - administration & dosage (13) 13
paclitaxel (13) 13
administration, oral (12) 12
antineoplastic agents (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
cell lung-cancer (12) 12
cisplatin (12) 12
fluorouracil (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Molecular Spectroscopy, ISSN 0022-2852, 01/2017, Volume 331, p. 44
Display Omitted 
Hydrogen | Analysis
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 03/2014, Volume 106, Issue 3, p. 1
  Pancreatic adenocarcinoma, even when resectable, remains highly lethal. Although surgical outcomes have improved considerably, median overall survival after... 
Chemotherapy | Pancreatic cancer | Genomics | Psychotherapy | Clinical trials | Metastasis
Journal Article
Journal Article
Journal of Molecular Spectroscopy, ISSN 0022-2852, 01/2017, Volume 331, pp. 44 - 52
Non-covalent interaction between PCl and H O was studied using matrix isolation infrared spectroscopy and computations. Computations indicated that the adducts... 
Matrix isolation | AIM analysis | Ab initio | Phosphorus bonding | NBO analysis | HYDROGEN-BOND | CENTER-DOT-N | COMPLEXES | PHYSICS, ATOMIC, MOLECULAR & CHEMICAL | ELECTRONEGATIVE SUBSTITUENTS | DFT CALCULATIONS | DI(TERTIARY PHOSPHINES) | NONCOVALENT INTERACTION | PNICOGEN BONDS | SPECTROSCOPY | VIBRATIONAL SPECTROSCOPY | INTERMOLECULAR INTERACTIONS
Journal Article
Journal of Molecular Structure, ISSN 0022-2860, 11/2015, Volume 1100, pp. 80 - 87
Gas phase reaction of phosphorus trichloride (PCl ) and methanol (CH OH) was carried out with different ratios of PCl :CH OH:N (1:1:1000, 1:2:1000 and... 
Methanol: gas phase reaction | DFT calculation | Phosphorus trichloride | Matrix isolation infrared spectroscopy | CENTER-DOT-N | AB-INITIO | NUCLEOPHILIC-SUBSTITUTION | COMPLEXES | CHEMISTRY, PHYSICAL | HALOGEN | HYDROGEN-BONDS | NONCOVALENT BONDS | PNICOGEN BONDS | TRIMETHYL-PHOSPHITE | Chloromethane | Methanol
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 21, pp. 3523 - 3529
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article